<DOC>
	<DOCNO>NCT00384514</DOCNO>
	<brief_summary>Study title : A Study Testing Safety Efficacy administration Blood-Borne Autologous Endothelial Progenitor Cells Alleviate Anginal Symptoms Myocardial Ischemia Patients Severe Anginal Syndrome Principle Investigator : Assoc . Prof. Damras , Tresukosol , M.D. , Head Cardiac Catherlization unit , Division Cardiology , Department Medicine , Faculty Medicine Siriraj Hospital , Mahidol University Study objective : To determine safety efficacy intracoronary injection blood-borne autologous EPCs relieve symptom angina pectoris symptomatic patient treat maximal medical therapy occlude coronary artery supply ischemic myocardium Study Design : Phase II , single center , non-randomized , open-label trial , Study population : Total expect . patient : 24 main selection criterion : - Patients chronic stable angina maximal medical therapy occlude coronary artery supply ischemic viable myocardial region show Sesta-mibi scan . On coronary angiography , occlude coronary artery must patent proximal segment least 30 mm least one side branch enable injection EPC vessel remain occluded despite attempted angioplasty effort . - Age 18-80 year - Ejection fraction &gt; 35 % Sesta-mibi scan - Sestamibi scan ( myocardial perfusion ) exercise dipyridamole , demonstrate regional reversible ischemia area relate occlude coronary artery . Investigational Product : At D-8 250 ml blood drawn patient production autologous EPCs ACPs ( VescellTM ) , On D0 , least 1.5 million EPCs viability &gt; 75 % suspend 6 ml sterile cell culture medium inject patient intracoronary artery . The study consist 4 period : Screening ( D-14to-9 &amp; D-8 , Treatment ( D0 ) , Acute Safety follow-up ( D1 &amp; D2 ) , Chronic follow-up ( D30 , D90 &amp; D180 ) period , total follow-up case 6 month . Evaluation criterion : Safety : no. &amp; duration adverse event &amp; serious adverse event Efficacy : - change baseline 1,3,6 month CCS , 6-minute walk test - change baseline 3 &amp; 6 month Sesta-mibi scan - change baseline 3 &amp; 6 month symptom-limited exercise time , exercise-induced ischemia &amp; METs Sesta-mibi scan Duration study : July 2004-December 2006</brief_summary>
	<brief_title>EPC Intracoronary Injection Patients With Chronic Stable Angina</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Patients chronic stable angina maximal medical therapy occlude coronary artery supply ischemic viable myocardial region show Sestamibi scan . On coronary angiography , occlude coronary artery must patent proximal segment least 30 mm least one side branch enable injection EPC vessel remain occluded despite attempted angioplasty effort . Patients candidate willing undergo CABG surgery . Age 18 80 year Male nonpregnant , nonlactating female Ejection fraction &gt; 35 % Sestamibi Sestamibi scan ( myocardial perfusion ) exercise dipyridamole , demonstrate regional reversible ischemia area relate occlude coronary artery . Informed consent obtain consent form sign Patients satisfy coronary angiography Sestamibi criterion Patient receive blood transfusion previous 4 week ( exclude potential nonautologous EPCs harvest blood ) . Inability communicate ( may interfere clinical evaluation Myocardial infarction precede 3 month Significant valvular disease valve replacement After heart transplantation Cardiomyopathy Renal failure ( creatinine 10 % upper limit accord hospital normograms ) Hepatic failure Anemia ( low 11mg/dl.hemoglobin female low 12 mg/dl male ) Abnormal coagulation test normal [ platelet , PT ( INR ) , PTT ] Stroke within precede 3 year Malignancy within precede 3 year Concurrent chronic acute infectious disease Severe concurrent medical disease ( e.g. , septicemia , HIV1,2/HBV/HCV infection , insulindependent diabetes mellitus , systemic lupus erythematosus , multiple sclerosis , amyotrophic lateral sclerosis ) Chronic immunomodulating cytotoxic drug treatment Patients rectal temp . 38.40C 2 consecutive day Patient unlikely available followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Coronary Artery disease chronic stable angina</keyword>
</DOC>